These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7086325)

  • 1. Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog.
    Ang VT; Jenkins JS
    J Endocrinol; 1982 Jun; 93(3):319-25. PubMed ID: 7086325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impermeability of the blood-cerebrospinal fluid barrier to 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus.
    Sørensen PS; Vilhardt H; Gjerris F; Warberg J
    Eur J Clin Invest; 1984 Dec; 14(6):435-9. PubMed ID: 6441719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]9-desglycinamide,8-arginine vasopressin: metabolism and in-vivo fate.
    Verhoef J; van den Wildenberg HM; van Nispen JW
    J Endocrinol; 1986 Sep; 110(3):557-62. PubMed ID: 3760747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of vasopressin and its analogs on blood coagulation in rats].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Fiziol Zh (1978); 1990; 36(3):25-30. PubMed ID: 2394244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does DDAVP (1-desamino-8-D-arginine-vasopressin) cross the blood-CSF barrier?
    Stegner H; Artman HG; Leake RD; Fisher DA
    Neuroendocrinology; 1983 Oct; 37(4):262-5. PubMed ID: 6633816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of DGAVP in plasma following intranasal and oral administration to healthy subjects.
    Westenberg HG; Hijman R; Wiegant VM; Laczi F; Van Ree JM
    Peptides; 1994; 15(6):1101-4. PubMed ID: 7991455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of DGAVP (Org 5667) across the blood-brain barrier in human subjects.
    Riekkinen P; Legros JJ; Sennef C; Jolkkonen J; Smitz S; Soininen H
    Peptides; 1987; 8(2):261-5. PubMed ID: 3588346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intranasal arginine vasopressin on human headache.
    Yang J; Lu L; Wang HC; Zhan HQ; Hai GF; Pan YJ; Lv QQ; Wang DX; Wu YQ; Li RR; Xue L; Wang XH; Deng XM; Liu XF; Qian YN; Deng ZK; Zhang ZJ; Zhan XH; Zhou XJ; Wang GL; Zhai JX; Wang JC
    Peptides; 2012 Nov; 38(1):100-4. PubMed ID: 22963731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of desglycinamide-arginine vasopressin across the blood-brain barrier in rats as evaluated by the unit impulse response methodology.
    van Bree JB; Tio S; de Boer AG; Danhof M; Verhoef JC; Breimer DD
    Pharm Res; 1990 Mar; 7(3):293-8. PubMed ID: 2339105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on vasopressin release and blood pressure during hemorrhage.
    Shimizu K; Nakao A
    Endocrinol Jpn; 1992 Oct; 39(5):517-23. PubMed ID: 1478192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
    Matsui K; Kimura T; Ota K; Iitake K; Shoji M; Inoue M; Yoshinaga K
    Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs.
    Liard JF
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tritiation of vasopressin analogues and their metabolic fate after intravenous injection in the rat.
    Janáky T; László FA; Morgat JL
    Acta Med Hung; 1984; 41(1):43-54. PubMed ID: 6739223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin in blood and third ventricle CSF during dehydration, thirst, and hemorrhage.
    Szczepańska-Sadowska E; Gray D; Simon-Oppermann C
    Am J Physiol; 1983 Oct; 245(4):R549-55. PubMed ID: 6624951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic hyponatremia on central and peripheral oxytocin and vasopressin secretion in rats.
    Iványi T; Dohanics J; Verbalis JG
    Neuroendocrinology; 1995 Apr; 61(4):412-20. PubMed ID: 7783854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin and desglycinamide vasopressin in post-traumatic amnesia.
    Jenkins JS; Mather HM; Coughlan AK; Jenkins DG
    Lancet; 1981 Jan; 1(8210):39. PubMed ID: 6109068
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of V2-receptor effect.
    Albuquerque CA; Nijland MJ; Ross MG
    J Matern Fetal Med; 1998; 7(4):177-82. PubMed ID: 9730483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin in cerebrospinal fluid and plasma of man, dog, and rat.
    Dogterom J; van Wimersma Greidanus TB; De Wied D
    Am J Physiol; 1978 May; 234(5):E463-7. PubMed ID: 645897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDAVP (1-desamino-8-D-arginine vasopressin) clearance rate.
    Stegner H; Artman HG; Leake RD; Fisher DA
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):204-6. PubMed ID: 6495988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.